Proprio, a company based in Seattle, has achieved a significant milestone by successfully conducting the first-in-human use of its Paradigm surgical technology platform for 3D visualisation.
The Paradigm platform is designed to replace traditional surgical navigation technologies, offering an innovative approach that combines light field imaging technology and artificial intelligence. This approach provides surgical teams with real-time 3D visualisation of both anatomical structures and the surgical environment.
The FDA cleared Paradigm in April, and it was used by Dr. Richard J. Bransford at the University of Washington Harborview Medical Center. Dr. Bransford described Paradigm as a "game-changer" for spinal surgery, allowing for better visualisation and potentially improved patient outcomes. The system captures high-definition, multimodal images during surgery, integrates them with preoperative scans, and provides real-time anatomical mapping.
This technology reduces the need for costly scans that can expose patients to radiation and disrupt clinical workflows, while also collecting valuable data to inform decision-making. Proprio aims to reshape surgical practices and reduce costs while increasing access to essential healthcare through its innovative platform.
Click here to read the original news story.